我的博文
Cytokeratin7、Cytokeratin20和Villin的免疫组化联合标记在确定转移癌原发部位中的应用
Useful Marker for Indentifying Tumor Origin
Primary Site | Marker |
Lung adenocarcinoma | TTF-1, NapsinA |
Breast CA | GATA3, ER, GCDFP-15 |
Urothelial CA | GATA3, UPII, S-100P, CK5/6, p63, CK20 |
Squamous cell CA | p40, CK5/6, p63, SOX2 |
RCC, clear cell type | PAX8/PAX2, RCCma, pVHL, KIM-1 |
Papillary RCC | P504S, RCCma, pVHL, PAX8, KIM-1 |
Translocational RCC | TFE3 |
HCC | Arginase-1, glypican-3 |
Adrenal cortical neoplasm | Mart-1, inhinbin-alpha, calretinin, SF-1 |
Melanoma | S-100, Mart-1, HMB45, MiTF, SOX10, PNL2 |
Merkel cell CA | CK20(perinuclear dot staining), MCPvy |
Mesothelial origin | Calretinin, WT-1, D2-40, CK5/6, mesothelin |
Neuroendocrine origin | Chromogranin, synaptophysin, CD56 |
Upper GI tract | CDH17, CDX2, CK20 |
Lower GI tract | SATB2, CDX2, CK20, CDH17 |
Intrahepatic cholangiocarcinoma | pVHL, CAIX |
Pancreas, acinar cell CA | Glypican-3, antitrypsin, Bcl-10 |
Pancrease, ductal ADC | MUC5AC, CK17, maspin, S-100P |
Pancrease, NET | PR, PAX8, PDX1, CDH17, islet-1 |
Pancrease, SPT | Nuclear beta-catenin, loss of E-cadherin, PR, CD10, vimentin, chromogranin negative |
Prostate, ADC | NKX3.1, PSA, PSAP, ERG |
Ovarian Serous CA | PAX8, ER, WT-1 |
Ovarian clear cell CA | pVHL, HNF-1B, KIM-1, PAX8 |
Endometrial ADC | PAX8/PAX2, ER, vimentin |
Endocerivival ADC | PAX8, p16, CEA, HPV in situ hybridization, loss of PAX2 |
Thyroid follicular cell origin | TTF-1, PAX8, thyroglobulin |
Thyroid medullary CA | Calcitionin, TTF-1, CEA |
Salivary duct CA | GATA3, AR, GCDFP-15, HER2 |
Thymic origin | PAX8, p63, CD5 |
Seminoma | SALL4, LIN28, OCT4, CD117, D2-40 |
Yolk sac tumor | SALL4, LIN28, glypican-3, AFP |
Embryonal CA | SALL4, LIN28, OCT4, NANOG, CD30, SOX2 |
Choriocarcinoma | GATA3, Beta-HCG, CD10 |
Sex cord stromal tumors | SF-1, inhibin-alpha, calretinin, FOXL2 |
Vascular tumor | ERG, CD31, CD34, Fli1 |
Synovial sarcoma | TLE1, cytokeratin |
Chordoma | Cytokeratin, S-100 |
Desmoplastic small round cell tumor | Cytokeratin, CD99, desmin, WT-1(N-terminus) |
Alveolar soft part sarcoma | TFE3 |
Rhabdomyosarcoma | Myogenin, desmin, MyoD1 |
Smooth muscle tumor | SMA, MSA, desmin, calponin |
Ewing sarcoma/PNET | NKX2.2, CD99, Fli-1 |
Myxoid and round cell liposarcoma | NY-ESO-1 |
Low-grade fibromyxoid sarcoma | MUC4 |
Epithelioid sarcoma | CD34, loss of INI1 |
Atypical lipomatous tumor | MDM2(MDM2 by FISH is a more sensitive and spectific test), CDK4 |
Histiocytosis X
| CD1a, S-100, Langerin(CD207) |
Angiomyolipoma | HMB45, SMA |
Gastrointestinal stromal tumor | CD117, DOG1 |
Solitary fibrous tumor | STAT6, CD34, Bcl-2, CD99 |
Myoepithelial CA | Cytokeratin and myoepithelial markers(may lose INI1) |
Myeloid sarcoma | CD43, CD34, MPO |
Follicular dendrtic cell tumor | CD21, CD35 |
Mast cell tumor | CD117, tryptase |
共0条评论